Montalescot G - Search Results

1

Biomarkers of Thrombosis in ST-Segment Elevation Myocardial Infarction: A Substudy of the ATOLL Trial Comparing Enoxaparin Versus Unfractionated Heparin.

Silvain J, O'Connor SA, Yan Y, Kerneis M, Hauguel-Moreau M, Zeitouni M, Overtchouk P, Ankri A, Brugier D, Vicaut E, Ecollan P, Galier S, Collet JP, Montalescot G; ATOLL Investigators. Silvain J, et al. Among authors: montalescot g. Am J Cardiovasc Drugs. 2018 Dec;18(6):503-511. doi: 10.1007/s40256-018-0294-z. Am J Cardiovasc Drugs. 2018. PMID: 30144017 Clinical Trial.

2

Lack of platelet-activating factor release during reversible myocardial ischaemia.

Montalescot G, Maclouf J, Drobinski G, Mencia-Huerta JM, Ankri A, Grosgogeat Y, Thomas D. Montalescot G, et al. Eur Heart J. 1992 Dec;13(12):1641-4. doi: 10.1093/oxfordjournals.eurheartj.a060118. Eur Heart J. 1992. PMID: 1289094

3

Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris.

Montalescot G, Drobinski G, Maclouf J, Maillet F, Salloum J, Ankri A, Kazatchkine M, Eugène L, Thomas D, Grosgogeat Y. Montalescot G, et al. Circulation. 1991 Nov;84(5):2054-62. doi: 10.1161/01.cir.84.5.2054. Circulation. 1991. PMID: 1934381

4

Early thromboxane release during pacing-induced myocardial ischemia with angiographically normal coronary arteries.

Montalescot G, Drobinski G, Maclouf J, Lellouche F, Ankri A, Moussallem N, Eugene L, Thomas D, Grosgogeat Y. Montalescot G, et al. Am Heart J. 1990 Dec;120(6 Pt 1):1445-7. doi: 10.1016/0002-8703(90)90261-u. Am Heart J. 1990. PMID: 2248190 No abstract available.

5

Clinical and ultrasound results after aortic valve replacement: intermediate-term follow-up with the St. Jude Medical prosthesis.

Montalescot G, Thomas D, Drobinski G, Evans JI, Vicaut E, Chatellier G, Whyte RI, Busquet P, Bejean-Lebuisson A, Grosgogeat Y. Montalescot G, et al. Am Heart J. 1989 Jul;118(1):104-13. doi: 10.1016/0002-8703(89)90079-3. Am Heart J. 1989. PMID: 2741777

6

Fibrinogen after coronary angioplasty as a risk factor for restenosis.

Montalescot G, Ankri A, Vicaut E, Drobinski G, Grosgogeat Y, Thomas D. Montalescot G, et al. Circulation. 1995 Jul 1;92(1):31-8. doi: 10.1161/01.cir.92.1.31. Circulation. 1995. PMID: 7788913

7

[Effects of ultrasonic energy on blood clots in vitro].

Drobinski G, Philippe F, Bucherer C, Ankri A, Lacombe C, Kremer D, Brisset D, Montalescot G, Thomas D, Grosgogeat Y. Drobinski G, et al. Among authors: montalescot g. Arch Mal Coeur Vaiss. 1993 Jun;86(6):915-20. Arch Mal Coeur Vaiss. 1993. PMID: 8274064 French.

8

Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters.

Bienvenu T, Ankri A, Chadefaux B, Montalescot G, Kamoun P. Bienvenu T, et al. Among authors: montalescot g. Thromb Res. 1993 Apr 15;70(2):123-9. doi: 10.1016/0049-3848(93)90153-f. Thromb Res. 1993. PMID: 8322283

9

Effects of ultrasound energy on thrombi in vitro.

Philippe F, Drobinski G, Bucherer C, Ankri A, Lacombe C, Kremer D, Brisset D, Montalescot G. Philippe F, et al. Among authors: montalescot g. Cathet Cardiovasc Diagn. 1993 Feb;28(2):173-8. doi: 10.1002/ccd.1810280217. Cathet Cardiovasc Diagn. 1993. PMID: 8448804

10

[Hyperhomocysteinemia in coronary artery diseases. Apropos of a study on 102 patients].

Blacher J, Montalescot G, Ankri A, Chadefaux-Vekemans B, Benzidia R, Grosgogeat Y, Kamoun P, Thomas D. Blacher J, et al. Among authors: montalescot g. Arch Mal Coeur Vaiss. 1996 Oct;89(10):1241-6. Arch Mal Coeur Vaiss. 1996. PMID: 8952820 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

809 results

Search Page

Filters